Compound Management Market By Type (Products and Service), By Sample Type (Bio Samples and Chemical Compounds), By Application (Drug Discovery, BioBanking, Gene Synthesis, and Other Applications) By End-Use (Pharmaceutical Companies, Contract Research Organizations, Biopharmaceutical Companies, and Other End-Uses), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Compound Management Market Overview

The global Compound Management market value was USD 427 million in 2021 and is forecast to grow at a CAGR. It is expected to grow at 16.2% between 2023-2032.

This market is being driven by several factors, including increased drug discovery activities and growth in the pharmaceutical industry and biotechnology industries. There is also a growing need for outsourced services.

Global Compound Management Market Analysis

Type Analysis

In 2021, 63% of the compound management market was dominated by the product segment. This product segment is expected to dominate the market due to the increasing demand for automation to manage compound libraries and compounds. An automated liquid handler can manage plates, vials, and tubes. It also has automated compound store equipment that allows for plate stamping compound tracking and reformatting.

Automated storage improves overall reliability and efficiency. This allows users to spend their time on more valuable activities. Many modern processes include the integration of storage systems with sample processing workstations that use pipetting robots. Innovative systems allow smaller businesses to take advantage of the system’s flexibility.

Sample Type Analysis

The chemical compound segment held a significant share in 2021, due to the high number of small molecules that are screened and assayed throughout drug discovery. The fastest expected CAGR is for biosamples at 16.8% during the forecast period. Market growth is being driven largely by increasing demand for personalized medications. Medical research is dependent on biological samples. Biobanks hold a variety of biospecimens that are in high demand because of the advances in cell-based research. The FDA recommends that biotechnology companies and pharmaceutical companies should be able to discover and develop biomarkers as part of their R&D process.

Application Analysis

The forecast period is expected to see a significant increase in drug discovery. The process of developing a drug can be expensive, long, and complicated. There are many advanced techniques that can help you check the process. High Throughput screening is used to screen large quantities of compounds with biological targets. Data on the activity of each target are gathered from a large library. Drug Discovery is used in order to find more active compounds. There is a high demand for drug discovery activities.

A growing number of companies involved in biomaterials collection and storage will also drive the growth of the biobanking sector. Biobanking will also be needed due to the growing importance placed on personalized medicines. The research will continue to require high-quality biospecimens. These factors are expected to help the segment grow.

End-Use Analysis

With a high share, the pharmaceutical companies segment dominated. This is due to increasing drug discovery activity which is leading to a higher demand for the compounds and thereby positively affecting the market growth. The segment of biopharmaceuticals is expected to show a high CAGR during the forecast period. The segment’s growth will be driven by an increase in biologic production and the emergence or biosimilar. This segment will also be driven by the rising R&D investment in biopharmaceutical firms and the increasing prevalence of chronic diseases.

Key Market Segments

By Type

• Products
• Service

By Sample Type

• Bio Samples
• Chemical Compounds

By Application

• Drug Discovery
• BioBanking
• Gene Synthesis
• Other Applications

By End-Use

• Pharmaceutical Companies
• Contract Research Organizations
• Biopharmaceutical Companies
• Other End-Uses

Market Dynamics

Automated storage solutions make it possible to store compounds more efficiently, increase sample integrity, and speed up the time required for sourcing samples. Innovative methods of high-throughput screening have been made possible by the use of automated sample management technology. Fully automated systems can be used to prepare assay plates, weigh and dissolve the compound and maintain libraries. These all improve drug discovery workflows and eliminate time-consuming, error-prone tasks. Software management tools have become more essential due to increasing sample collection sizes, diversity, and size. Many companies preferred to manage their sample management software systems themselves. However, this can often prove costly. Many now turn to outsource for solutions.

Companies are increasingly collaborating and leveraging their expertise. This will drive compound management. Many organizations are expanding existing strategic partnerships and working with venture capitalists to fund funding and private companies and public institutions to exploit any patented technology. The growth of partnerships between public and private entities will accelerate drug discovery processes. This in turn will increase global demand.

Regional Analysis

Geographically, North America dominated the compound management market in 2021, with a 41% share. This is due to the presence of strong pharmaceutical and biotechnology companies involved in drug development activity. There is therefore a rising demand for services in the region. The region’s growth is due to an increase in disease-related mortality and morbidity.

The Asia Pacific is expected the most rapid growth in the forecast period. The growth of the market will be driven by ongoing studies in drug discovery and private-public collaborations. Japan was the country with the highest market share thanks to government support. Japan’s revised Pharmaceutical Affairs Law encourages research on tissue diagnosis and cancer. This is expected to increase the demand for compound management in Japan.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

Market players use a variety of strategies to launch products, merge and acquire companies, and collaborate with others. In January 2019, Beckman Coulter Life Sciences, a California-based liquid handling business, announced that it had acquired Labcyte to increase its laboratory automation business.

Маrkеt Кеу Рlауеrѕ:

• Brooks Life Sciences
• Hamilton Company
• Tecan Group Ltd.
• ascent
• Evotec SE
• Titian Service Limited
• LiCONiC systems
• Beckman Coulter Inc.
• Other Key Players

For the Compound Management Market research study, the following years have been considered to estimate the market size: